AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Moffitt Cancer Center launches new podcast, The ImmunoVerse, where Patrick Hwu, MD, will discuss immunotherapy research with ...

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

Revvity and Watchmaker Genomics are working to bring more flexible and scalable NGS solutions to researchers worldwide.

Researchers say study underscores how psychedelics may help dial down inflammation and reset brain-immune interactions.

"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...

Revvity serves the pharmaceutical and biotech industries, diagnostic labs, academia. and governments in more than 160 ...

Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.